The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
Premium- Novartis (NYSE:NVS) is gaining slowly in pre-market trading after Tuesday’s announcement that the company terminated licensing responsibilities with Idenix (NASDAQ:IDIX). NVS gapped down 5% on … Continue Reading
Read nowLong Ideas - Sources at Roche (OTCQX: RHHBY) told PropThink on Wednesday that products being jointly developed with Halozyme Therapeutics (NASDAQ: HALO) will not face issues seen with … Continue Reading
Read nowLong Ideas - Botox producer Allergan, Inc. (NYSE:AGN) reported its second quarter earnings today, with substantial all-around growth. Net income rose 19% from the last year to $296 … Continue Reading
Read nowLong Ideas - Navidea BioPharma (NASDAQ:NAVB) announced last night that it has entered into a licensing agreement with Alseres Pharmaceuticals (OTC:ALSE) for the development of ALSE’s Altropane imaging … Continue Reading
Read nowLong Ideas - Depomed Inc. (NASDAQ:DEPO) announced last night that it has submitted a New Drug Application to the FDA for  Serada, the company’s extended release formulation of … Continue Reading
Read nowLong Ideas - An announcement this morning from MAP Pharmaceuticals (NASDAQ:MAPP) said that the company will be offering nearly 4 million shares of the company’s common stock at … Continue Reading
Read now- Life Technology’s (NASDAQ:LIFE) second quarter’s earnings miss was disappointing, with the company reporting adjusted earnings per share of $0.96 and revenues of $949 million, versus … Continue Reading
Read now
